[Featured Stocks] Rapid Increase in COVID-19 Patients... Diagnostic Kit Stocks '↑'

Diagnostic kit stocks are showing strength. It appears that the recent surge in COVID-19 patients has had an impact.

Suzentec was trading at 7,790 won as of 10:11 AM on the 2nd, up 1,580 won (25.44%) compared to the previous trading day. LabGenomics, Humasis, and Seegene are also showing strong performance.

According to the Korea Disease Control and Prevention Agency, the number of new COVID-19 hospitalizations increased 5.1 times over the past four weeks, with 91 cases in the first week of July, 148 in the second week, 225 in the third week, and 465 in the fourth week. The virus detection rate rose from 7.4% in the fourth week of June to 24.6% in the third week of July, an increase of 17.2 percentage points over four weeks.